Article
Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation.
Transfusion - 1 May 1995
Wagner S J, Cifone M A, Murli H, Dodd R Y, Myhr B
Abstract excerpt
BACKGROUND: The risk of adverse consequences of virus-inactivation procedures for plasma and cellular blood components must be less than the risk of transfusion-associated viral disease. Previous studies demonstrated that methylene blue, which is currently used in Europe for virus inactivation in...
Topics
- Animals
- Cell Death
- Lymphoma
- Methylene Blue
- Mice
- Mutagens
- Mutation
- Thymidine Kinase
